Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Victory Capital Management Inc.

Victory Capital Management Inc. lessened its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 25.8% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 36,840 shares of the company’s stock after selling 12,779 shares during the period. Victory Capital Management Inc.’s holdings in Henry Schein were worth $2,361,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Summit Securities Group LLC acquired a new position in shares of Henry Schein during the second quarter valued at approximately $31,000. Beach Investment Counsel Inc. PA purchased a new position in Henry Schein in the 2nd quarter valued at $37,000. Blue Trust Inc. boosted its stake in Henry Schein by 104.2% during the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock worth $60,000 after purchasing an additional 475 shares during the last quarter. Mather Group LLC. purchased a new stake in shares of Henry Schein during the first quarter worth $97,000. Finally, Palisade Asset Management LLC acquired a new stake in shares of Henry Schein in the first quarter valued at about $113,000. 96.62% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Henry Schein

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the company’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the transaction, the senior vice president now directly owns 71,833 shares in the company, valued at $4,978,026.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.14% of the stock is owned by insiders.

Henry Schein Stock Up 2.0 %

Shares of NASDAQ:HSIC opened at $71.24 on Wednesday. The company has a market capitalization of $9.12 billion, a price-to-earnings ratio of 24.07, a PEG ratio of 1.88 and a beta of 0.86. Henry Schein, Inc. has a 12-month low of $60.01 and a 12-month high of $82.63. The business has a 50-day moving average price of $69.32 and a 200 day moving average price of $70.43. The company has a current ratio of 1.55, a quick ratio of 0.90 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.01. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The business had revenue of $3.10 billion during the quarter, compared to analysts’ expectations of $3.27 billion. During the same period last year, the business earned $1.31 earnings per share. The business’s revenue for the quarter was up .0% on a year-over-year basis. Sell-side analysts expect that Henry Schein, Inc. will post 4.75 EPS for the current year.

Analyst Ratings Changes

Several analysts recently issued reports on HSIC shares. Evercore ISI dropped their price objective on shares of Henry Schein from $72.00 to $70.00 and set an “in-line” rating for the company in a research note on Wednesday, August 7th. Robert W. Baird cut their price target on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a report on Wednesday, August 7th. Barrington Research reduced their price objective on Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 7th. UBS Group dropped their target price on Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a report on Wednesday, August 7th. Finally, JPMorgan Chase & Co. reduced their price target on Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a report on Monday, August 12th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $77.10.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.